BRPI0508858A - solução oftálmica incluindo carboximetilcelulose de sódio e hidroxipropilmetilcelulose - Google Patents

solução oftálmica incluindo carboximetilcelulose de sódio e hidroxipropilmetilcelulose

Info

Publication number
BRPI0508858A
BRPI0508858A BRPI0508858-5A BRPI0508858A BRPI0508858A BR PI0508858 A BRPI0508858 A BR PI0508858A BR PI0508858 A BRPI0508858 A BR PI0508858A BR PI0508858 A BRPI0508858 A BR PI0508858A
Authority
BR
Brazil
Prior art keywords
ophthalmic solution
solution including
hydroxypropyl methylcellulose
sodium carboxymethylcellulose
including sodium
Prior art date
Application number
BRPI0508858-5A
Other languages
English (en)
Inventor
Fu-Pao Tsao
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BRPI0508858A publication Critical patent/BRPI0508858A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/40—Peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Abstract

SOLUçãO OFTáLMICA INCLUINDO CARBOXIMETILCELULOSE DE SóDIO E HIDROXIPROPILMETILCELULOSE. A presente invenção refere-se a uma solução oftálmica incluindo uma fonte de peroxido de hidrogênio em uma quantidade suficiente para resultar entre cerca de 0,001% e cerca de 0,01% em peso de peroxido de hidrogênio estabilizado em dita formulação com um conservante, um ou mais estabilizadores de peroxido de hidrogênio ocularmente compatíveis, hidroxipropilmetilcelulose e carboximetilcelulose de sódio, bem como composições farmacêuticas incluindo tais soluções, são fornecidos.
BRPI0508858-5A 2004-03-17 2005-03-16 solução oftálmica incluindo carboximetilcelulose de sódio e hidroxipropilmetilcelulose BRPI0508858A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US55388004P 2004-03-17 2004-03-17
PCT/EP2005/002804 WO2005089715A1 (en) 2004-03-17 2005-03-16 Ophthalmic solution comprising sodium carboxymethylcellulose and hydroxypropylmethylcellulose

Publications (1)

Publication Number Publication Date
BRPI0508858A true BRPI0508858A (pt) 2007-08-28

Family

ID=34962605

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0508858-5A BRPI0508858A (pt) 2004-03-17 2005-03-16 solução oftálmica incluindo carboximetilcelulose de sódio e hidroxipropilmetilcelulose

Country Status (15)

Country Link
US (4) US20050244509A1 (pt)
EP (1) EP1732511A1 (pt)
JP (1) JP2007529458A (pt)
KR (1) KR20070005625A (pt)
CN (1) CN1933812A (pt)
AU (1) AU2005224012B2 (pt)
BR (1) BRPI0508858A (pt)
CA (1) CA2557795A1 (pt)
EC (1) ECSP066808A (pt)
IL (1) IL177725A0 (pt)
MA (1) MA28507B1 (pt)
NO (1) NO20064661L (pt)
RU (1) RU2006136092A (pt)
TN (1) TNSN06293A1 (pt)
WO (1) WO2005089715A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070048389A1 (en) * 2005-08-26 2007-03-01 Fu-Pao Tsao Stabilized and preserved ketotifen ophthalmic compositions
US20070048388A1 (en) * 2005-08-26 2007-03-01 Fu-Pao Tsao Stabilized and preserved ketotifen ophthalmic compositions
CA2646424C (en) 2006-03-17 2015-12-29 Johnson & Johnson Vision Care, Inc. Methods for stabilizing oxidatively unstable compositions
US20070264226A1 (en) * 2006-05-10 2007-11-15 Karagoezian Hampar L Synergistically enhanced disinfecting solutions
AU2013224663B2 (en) * 2007-08-31 2015-01-15 Alcon Inc. Contact Lens Products
TWI551305B (zh) * 2007-08-31 2016-10-01 諾華公司 相對黏稠封裝溶液之用途
US20090239775A1 (en) * 2008-03-19 2009-09-24 Collins Gary L Ophthalmic solutions displaying improved efficacy
TW201127423A (en) 2009-12-17 2011-08-16 Alcon Res Ltd Ophthalmic solutions with improved disinfection profiles
US20150000936A1 (en) * 2011-12-13 2015-01-01 Schlumberger Technology Corporation Energization of an element with a thermally expandable material
AU2016364319B2 (en) 2015-12-03 2019-06-27 Alcon Inc. Contact lens packaging solutions
US11185487B2 (en) * 2015-12-28 2021-11-30 Johnson & Johnson Consumer Inc. Hair growth composition and method
CN107041892B (zh) * 2016-07-12 2021-02-26 合肥九研医药科技开发有限公司 羟丙基甲基纤维素在上消化道黏膜损伤护理上的应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880601A (en) * 1985-09-27 1989-11-14 Laboratoires, P.O.S. Hydrogen peroxide disinfecting system for contact lenses
US5607698A (en) * 1988-08-04 1997-03-04 Ciba-Geigy Corporation Method of preserving ophthalmic solution and compositions therefor
US5888493A (en) * 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
AU2001293851A1 (en) * 2000-09-28 2002-04-08 Novartis Ag Stabilized hydrogen peroxide solutions
PE20030729A1 (es) * 2002-01-18 2003-10-21 Novartis Ag Metodos para conservar soluciones oftalmicas y soluciones oftalmicas conservadas

Also Published As

Publication number Publication date
ECSP066808A (es) 2006-11-16
JP2007529458A (ja) 2007-10-25
NO20064661L (no) 2006-12-14
US20100143493A1 (en) 2010-06-10
WO2005089715A1 (en) 2005-09-29
IL177725A0 (en) 2006-12-31
AU2005224012A1 (en) 2005-09-29
US20080096978A1 (en) 2008-04-24
US20050244509A1 (en) 2005-11-03
MA28507B1 (fr) 2007-04-03
US20120220961A1 (en) 2012-08-30
RU2006136092A (ru) 2008-04-27
CA2557795A1 (en) 2005-09-29
KR20070005625A (ko) 2007-01-10
CN1933812A (zh) 2007-03-21
EP1732511A1 (en) 2006-12-20
AU2005224012B2 (en) 2009-07-02
TNSN06293A1 (en) 2007-12-03

Similar Documents

Publication Publication Date Title
BRPI0508858A (pt) solução oftálmica incluindo carboximetilcelulose de sódio e hidroxipropilmetilcelulose
BRPI0911035B8 (pt) ativadores de pirrolidinona glicoquinase
EA025267B1 (ru) Водная фармацевтическая композиция этанерцепта, стабилизированная глутаматом
BR112012021771A2 (pt) métodos de uso de inibidores de contransportadores de sódio-glicose 1 e 2.
GEP20135907B (en) L-(piperidin-4-yl)-pyrazole derivatives as gpr 119 modulators
PE20120648A1 (es) Compuestos de 4-isopropilfenilglucitol como inhibidores de sglt1
SG155961A1 (en) Pyrazoles as 11-beta-hsd-1
CO6541634A2 (es) Composición de cereal hidrolizado
NO20074391L (no) CIS-2,4,5-triaryl-imidazoliner og deres anvendelse som anti-cancer medikamenter
BRPI0717035B8 (pt) moduladores de benzotriazol cinase
CL2011001082A1 (es) Compuestos derivados de amino-tetrahidropiranos sustituidos con heterociclos, composicion farmaceutica; y uso en el tratamiento de una afeccion seleccionada de resistencia a la insulina, hiperglicemia y diabetes de tipo 2.
EA201170703A1 (ru) Производные адамантилбензамида
EA200870216A1 (ru) Амидо соединения и их применение в качестве лекарственных средств
BR112012013847A2 (pt) novos derivados de indolinona ciclopropano
NO20083669L (no) 4-aryl-2amino-pyrimidiner eller 4-aryl-2-aminoalkylpyrimidiner som jak-2-modulatorer og fremgangsmater for anvendelse derav
BRPI0608291A2 (pt) agente imunossupressor e agente antitumoral que compreendem composto heterocìclico como ingrediente ativo
DE602008002567D1 (de) Neue substituierte arylsulphonylglycine, ihre herstellung und ihre verwendung als pharmazeutische zusammensetzungen
MX2010009922A (es) Activadores de piridazinona glucocinasa.
JO2770B1 (en) Organic compounds
UY31138A1 (es) Derivados de indolinonas sustituidas, composiciones conteniendolos y aplicaciones
MX2009011554A (es) Preparacion solida estable conteniendo un derivado de 4,5-epoximorfinano.
TN2010000074A1 (en) Cyclic depsipeptides
ECSP109961A (es) Derivados de indol-2-ona disustituidos en 3, su preparación y su aplicación en terapéutica
MA33384B1 (fr) Sulfonamides hétérocycliques, leurs utilisations et compositions pharmaceutiques les contenant
BR112012013119A2 (pt) derivados de 1-amino-piperidina-pirrolidina-diona espirocondensada com atividade pesticida.

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B04C Request for examination: application reinstated [chapter 4.3 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.